Please use this identifier to cite or link to this item:
|Title:||Thromboembolism during neoadjuvant therapy for gastrointestinal cancer.|
|Epworth Authors:||Smart, Philip|
Lynch, A. Craig
|Other Authors:||Burbury, Kate|
|Citation:||Am J Clin Oncol. 2014 Dec;37(6):627-34. doi: 10.1097/COC.0b013e318280d78a.|
|Abstract:||Thromboembolism a common, costly, and morbid complication that is also associated with decreased survival in cancer patients. The risk of thromboembolism in cancer patients is underappreciated. In addition to symptomatic deep venous thrombosis and pulmonary embolism, asymptomatic and arterial thromboembolic events are important consideration in ambulatory cancer patients receiving neoadjuvant chemoradiotherapy (nCRT). No specific randomized trial examining thromboprophylaxis (TP) during nCRT for gastrointestinal cancer has been performed, and none is accruing. Most guidelines currently recommend against TP in ambulatory cancer patients due to a lack of data rather than proof of harm or lack of efficacy. It is clear that robust data are urgently required, and that treatment with nCRT in patients with gastrointestinal malignancy is not an indication for routine pharmacological TP at the present time|
|Journal Title:||American Journal of Clinical Oncology|
|Affiliated Organisations:||Departments of Cancer Surgery Haematology, Peter MacCallum Cancer Centre|
|Type of Clinical Study or Trial:||Review|
|Appears in Collections:||Cancer Services|
General Surgery and Gastroenterology
Files in This Item:
There are no files associated with this item.
Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.